ArticleThe Journal of clinical investigation2022

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.

Sergio Rutella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.